# Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)

> **NCT06826859** · PHASE1,PHASE2 · RECRUITING · sponsor: **Thomas Jefferson University** · enrollment: 400 (estimated)

## Conditions studied

- Preterm Birth
- Preeclampsia

## Interventions

- **DRUG:** Daily aspirin (ASA)
- **DRUG:** Split dose aspirin (ASA)

## Key facts

- **NCT ID:** NCT06826859
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-26
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06826859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06826859, "Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06826859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*